Document is current
Any future updates will be listed below
-
Authors
Ginzberg, Sara P. https://orcid.org/0000-0003-1657-0617
Soegaard Ballester, Jacqueline M.
Wirtalla, Christopher J.
Morales, Knashawn H.
Pryma, Daniel A.
Mandel, Susan J.
Kelz, Rachel R.
Wachtel, Heather
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2-TR001879)
- License Information
-
More Information
Article History
Received: 7 November 2022
Accepted: 12 January 2023
First Online: 7 February 2023
Disclosure
: Daniel A. Pryma reports grants and honoraria from Siemens, Lantheus, Point BioPharma, Five Eleven Pharma, and Fusion Pharmaceuticals; a grant from Nordic Nanovector; and honoraria from Curium, Molecular Targeting Technologies, and Actinium Pharmaceuticals. The remaining authors have no conflicts of interest.
